Walleye Trading
AGIO icon

Walleye Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Walleye Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,400
Closed -$56.2K – 4263
2025
Q3 		$56.2K Buy
+1,400
New +$52.7K ﹤0.01% 3926
2024
Q1 		– Sell
-3,200
Closed -$71.3K – 4686
2023
Q4 		$71.3K Buy
3,200
+300
+10% +$6.72K ﹤0.01% 4255
2023
Q3 		$71.8K Buy
+2,900
New +$76.7K ﹤0.01% 4102
2022
Q4 		– Sell
-5,900
Closed -$167K – 4919
2022
Q3 		$167K Buy
+5,900
New +$158K ﹤0.01% 3815
2022
Q2 		– Sell
-22,300
Closed -$649K – 5054
2022
Q1 		$649K Buy
22,300
+16,200
+266% +$495K ﹤0.01% 2640
2021
Q4 		$201K Buy
6,100
+3,400
+126% +$137K ﹤0.01% 3853
2021
Q3 		$125K Buy
+2,700
New +$130K ﹤0.01% 4235
2021
Q1 		– Sell
-3,700
Closed -$160K – 4739
2020
Q4 		$160K Buy
+3,700
New +$146K ﹤0.01% 3668
2020
Q3 		– Sell
-18,700
Closed -$1M – 4038
2020
Q2 		$1M Sell
18,700
-5,600
-23% -$259K 0.01% 1661
2020
Q1 		$862K Buy
24,300
+14,000
+136% +$647K 0.01% 1416
2019
Q4 		$492K Sell
10,300
-13,100
-56% -$495K ﹤0.01% 2421
2019
Q3 		$758K Buy
23,400
+10,400
+80% +$431K 0.01% 1802
2019
Q2 		$648K Sell
13,000
-7,000
-35% -$374K 0.01% 1980
2019
Q1 		$1.35M Sell
20,000
-11,900
-37% -$693K 0.01% 1396
2018
Q4 		$1.47M Buy
31,900
+24,600
+337% +$1.52M 0.01% 1326
2018
Q3 		$563K Buy
7,300
+5,600
+329% +$450K ﹤0.01% 2761
2018
Q2 		$143K Buy
+1,700
New +$148K ﹤0.01% 3849

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Walleye Trading's AGIO Position: Q1 2024 in Review

Walleye Trading sold out of Agios Pharmaceuticals (AGIO) in Q1 2024, closing a stake of 20,321 shares — an estimated $453K sold.

Walleye Trading first reported a position in AGIO in Q2 2017 and held it in 11 quarters. The position peaked at $1.13M in Q4 2018. 186 funds tracked by Wall St. Rank hold AGIO as of Q1 2024.

  • Walleye Trading reported no remaining Agios Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 20,321 Agios Pharmaceuticals shares in Q1 2024, an estimated $453K.
  • Walleye Trading first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 11 quarters.
  • Walleye Trading's Agios Pharmaceuticals position peaked at $1.13M in Q4 2018.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.